An observational study in Intraoperative Complications, Intraoperative Bleeding and Intraoperative Blood Loss, sponsored by University of Maryland, Baltimore. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years to 88 Years. Per ClinicalTrials.gov, last updated 2026-09-04.
Sponsored by University of Maryland, Baltimore · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Intraoperative Complications with a site in United States — 4 open to participants now, 4 under way, none of them phase 3. Intraoperative Complications · United States.
Among the 13 studies in Intraoperative Complications with a site in United States, this one is one of 3 that started in 2025, is one of 7 observational ones, and was the 11th registered.
92 studies on the registry are indexed under Intraoperative Complications; 19 are open to participants now.
Browse Intraoperative Complications studies →4 of the 13 studies in Intraoperative Complications with a site in United States are open now. Recruiting first, the newest first:
University of Pittsburgh · Sites in United States
Ages 18+
University of Pittsburgh · Sites in United States
Ages 18+
Boston Children's Hospital · Sites in United States
Ages 8–35 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 14 Intraoperative Complications studies recruiting now, 6 (43%) set no upper age limit and 6 (43%) stop at 75 or younger; 3 take children under 18; 2 take healthy volunteers.
This study: 18 Years to 88 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 1 · Phase 3 3
First in 2007; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 173 is below the median of 200 across 39 observational studies indexed under Intraoperative Complications.
Median enrollment 54 across the 6 interventional studies, 244 across the 7 observational. Of the 8 that completed or were terminated, 4 (50%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 13 has an industry lead sponsor. The 10 most frequent:
University of Maryland, Baltimore is the lead sponsor of 700 studies on the registry; 131 are open to participants now.
Of its 92 completed or terminated interventional studies of FDA-regulated products, 66 (72%) have results posted.
University of Maryland, Baltimore has 1 study filed under Intraoperative Complications — fewer than ten, so there is no comparison to draw.
2 of the studies in Intraoperative Complications with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06450834University of Maryland, BaltimoreOstene in Thoracolumbar Decompression and Fusion Evaluated With VIBE | 2027-06 |
| NCT04439552Boston Children's HospitalfMRI and IVCM Cornea Microscopy of CXL in Keratoconus | 2027-08 |
Add all 2 to your calendar (.ics) → With an account.
Among the 13 studies in Intraoperative Complications with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
In spine surgery, it is important to try to minimize bleeding. In particular, spine surgery often involves inserting hardware into bone, and/or removing bone in the spine. Because the bone in the spine contains blood vessels, there can often be bleeding from the bone itself that is difficult to stop completely. One way to stop bone bleeding is through the use of wax-like materials, which plug the bleeding bone and act as a physical barrier to stop bleeding. One example is Ostene bone hemostasis material, which has the advantage of being "water soluble", meaning it will dissolve naturally over time. The purpose of this study is to evaluate how well Ostene does at decreasing bleeding, by using a recognized scale called the validated intraoperative bleeding severity scale, abbreviated as "VIBe". In this study, the investigators will record the bleeding severity throughout multiple time points in surgery using this scale, and then the investigators will compare the measurements to patients in the past who did not receive Ostene. Overall, this research will help measure how well Ostene decreases bleeding.
A propensity-score matched cohort analysis will be constructed to compare patients who received Ostene to patients who did not receive Ostene (will use data from past study conducted from 2021-April 2023 to construct matched control cohort).
Adult patients 18 to 88 years old undergoing elective thoracolumbar decompression, instrumentation, and fusion procedures with an open, posterior approach and without indication for trauma, tumor, or suspected/confirmed infection, emergent triage status, an anterior or lateral approach, or a minimally invasive approach
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients who received Ostene during their thoracolumbar spine surgery
Device: Ostene
Propensity score matched cohort from previous study that did not receive Ostene during their spine surgery
Soluble Bone Hemostasis Implant Material
Intraoperative blood transfusion
binary and number of units
Time frame: Intraoperative
postoperative blood transfusion
binary and number of units
Time frame: 3 days
preoperative hemoglobin/hematocrit
Time frame: Immediately preoperative
3 days before surgery of preoperative hemoglobin/hematocrit
Time frame: 3 days
postoperative hemoglobin/hematocrit
Time frame: 3 days
days after surgery of postoperative hemoglobin/hematocrit
Time frame: 3 days
postoperative drain output
average daily drain output, total drain output
Time frame: From the first day postoperatively then measured daily, until the patient is discharged, up to 1 year
Presence of Deep Vein Thrombosis
Time frame: From the date of surgery until 1 year follow up appointment
Presence of Pulmonary Embolism
Time frame: From the date of surgery until 1 year follow up appointment
Presence of postoperative complication requiring medical intervention
Time frame: From the date of surgery until 1 year follow up appointment
length of stay
Time frame: From the date of surgery until discharge up to 1 year
30-day readmissions
Time frame: readmission within 30 days
30-day reoperations
Time frame: reoperation within 30 days
30-day emergency department visits
Time frame: ED visits within 30 days
cost
total hospital billing for procedure and total episode of stay and/or insurance reimbursement amount
Time frame: From the date of surgery until discharge up to 1 year
Plan to share: No — There is currently no plan to share IPD data with any other researchers.
No publications or documents are linked to this record.
Started Jan 2025 (actual). Primary completion is estimated for Jun 2027, 29 months after the start.
Of 23 observational studies under Intraoperative Complications, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 17. This study's planned 29 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Intraoperative Complications →
University of Maryland, Baltimore →